Academic Journal
Q1Journal of the American Society of Nephrology : JASN
About Journal of the American Society of Nephrology : JASN
Journal of the American Society of Nephrology : JASN is a scholarly journal published by Wolters Kluwer Health. SCImago 2025 places it in Q1 with an SJR of 3.421 and an H-index of 342.
Its listed coverage is 1990-2026 and its research categories include Critical Care and Intensive Care Medicine (Q1); Epidemiology (Q1); Medicine (miscellaneous) (Q1); Nephrology (Q1); Transplantation (Q1). The 2025 dataset reports 406 documents and 4012 citations across the latest three-year reporting window.
The Journal of the American Society of Nephrology (JASN) is one of the premier scientific journals in the field of nephrology. Published monthly by the American Society of Nephrology (ASN), JASN serves as a cornerstone for research, innovation, and clinical practice in kidney disease, offering groundbreaking insights into renal physiology, pathology, and therapeutic advancements.
A Trusted Source for Nephrology Research
JASN has a rich history of providing high-quality, peer-reviewed articles that contribute to the understanding and treatment of kidney diseases. The journal features a diverse range of research topics, from basic science to clinical trials, and covers both adult and pediatric nephrology. Researchers, clinicians, and healthcare professionals rely on JASN to stay updated with the latest findings in kidney disease management and renal care.
Focus Areas of JASN
The Journal of the American Society of Nephrology covers a wide variety of nephrology-related topics. Some of the key areas include:
-
Kidney Disease Mechanisms: JASN explores the underlying causes of kidney diseases, including genetic factors, inflammation, and the molecular pathways involved in kidney injury and repair.
-
Dialysis and Renal Replacement Therapies: The journal publishes research on dialysis treatments, including hemodialysis and peritoneal dialysis, as well as advancements in renal transplantation and kidney replacement therapies.
-
Chronic Kidney Disease (CKD): Articles on CKD focus on early detection, progression, and management strategies, including pharmacological interventions and lifestyle changes to slow the disease’s progression.
-
Acute Kidney Injury (AKI): JASN offers insights into the pathophysiology of AKI, its risk factors, diagnosis, and treatment options, helping clinicians manage this serious and often reversible condition.
-
Renal Pharmacology: The journal delves into the pharmacological management of kidney diseases, evaluating new drugs, clinical trials, and therapeutic interventions that can improve outcomes for patients with kidney-related conditions.
-
Innovative Therapeutics: JASN is at the forefront of reporting on emerging therapeutic approaches for kidney disease, including gene therapy, stem cell therapy, and novel pharmacological agents.
Impact on Clinical Practice
JASN is not only a resource for researchers but also an invaluable tool for clinicians. The journal bridges the gap between laboratory research and clinical application, providing physicians with the latest evidence-based practices to improve patient care. By incorporating cutting-edge research into everyday practice, healthcare professionals can enhance their diagnostic capabilities and treatment strategies, improving outcomes for individuals with kidney diseases.
Global Reach and Influence
With a global readership, JASN is widely regarded as one of the most influential nephrology journals worldwide. The journal is accessible to researchers, practitioners, and students, ensuring that important discoveries reach a broad audience. Its extensive archive of high-impact articles provides a comprehensive repository for those interested in the scientific advancements and clinical applications in nephrology.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The Journal of the American Society of Nephrology (JASN) is a prominent, peer-reviewed medical journal dedicated to the field of nephrology. As the official journal of the American Society of Nephrology (ASN), JASN publishes cutting-edge research and findings related to kidney disease, its treatment, and its management. The journal’s primary focus is on advancing our understanding of the kidney's functions and the pathophysiology of kidney-related diseases.
Key Areas of Focus in JASN
JASN covers a broad range of topics within nephrology, contributing significantly to the research community. Its core areas of focus include:
-
Basic and Clinical Research: The journal includes a variety of original research studies, from basic science to clinical trials, that explore the underlying mechanisms of kidney function, disease progression, and therapeutic interventions. This includes investigations into renal fibrosis, glomerular disease, and kidney transplantation.
-
Kidney Disease Prevention and Management: Another key area of interest is the prevention and management of chronic kidney disease (CKD) and end-stage renal disease (ESRD). JASN presents studies on innovative approaches for improving patient outcomes through early diagnosis, medical treatments, and lifestyle modifications.
-
Kidney Transplantation: Research on kidney transplantation is a cornerstone of JASN. The journal publishes studies on transplant immunology, organ rejection mechanisms, and advancements in transplant techniques that aim to increase the success rates and longevity of kidney transplants.
-
Dialysis: Dialysis is a critical component in the treatment of kidney failure. JASN features articles on the latest advancements in dialysis methods, including hemodialysis and peritoneal dialysis, as well as studies aimed at improving the quality of life for dialysis patients.
-
Innovative Therapeutic Strategies: JASN highlights groundbreaking research into new therapies for kidney diseases, focusing on novel drugs, biomarker identification, and personalized treatment strategies. The journal plays an essential role in bridging the gap between laboratory discoveries and clinical applications.
-
Kidney Physiology and Pathophysiology: The journal delves into the intricate mechanisms of kidney function, providing a deep understanding of renal physiology and the pathological processes that lead to kidney dysfunction. Studies on fluid and electrolyte balance, glomerular filtration rate (GFR), and renal tubular function are regularly featured.
Impact on the Nephrology Community
JASN has earned its reputation as one of the most respected journals in nephrology. Its articles are cited widely, and it serves as a vital resource for nephrologists, clinicians, researchers, and healthcare professionals around the world. Through its comprehensive and rigorous approach to scientific publication, JASN not only supports the advancement of nephrology but also facilitates the translation of research into clinical practice, improving patient care.
Educational Resources and Reviews
In addition to original research articles, JASN publishes educational content, including reviews and commentaries that provide critical insights into emerging trends and technologies in nephrology. These educational articles serve as a resource for both professionals seeking to expand their knowledge and those involved in the training and education of future nephrologists.
Recent Research Articles
Latest publications matched automatically by ISSN.
Kidney-on-Chip and Organoid Models
Abigail Daily, Nanditha Anandakrishnan, Jonathan Haydak, Jonathan Himmelfarb et al.
2026-09-08 · DOI: 10.1681/asn.0000001272Quantum Dot–Based Fluorescent Lateral Flow Immunoassay Strip for Rapid Detection of Anti-nephrin Autoantibodies in Idiopathic Nephrotic Syndrome
Mingyu Lai, Rui Gu, Jiayi Shen, Tong Shao et al.
2026-09-08 · DOI: 10.1681/asn.0000001246Macrophage IgG Recycling Couples Glomerular IgG Accumulation to Podocyte Senescence in Obesity-Related Glomerulopathy
Zikang Liu, Binbin Dai, Yuxuan Jin, Jiwen Bao et al.
2026-09-04 · DOI: 10.1681/asn.0000001243Risk, Not Just Rate
Harish Seethapathy, Sahir Kalim, Sagar U. Nigwekar
2026-09-03 · DOI: 10.1681/asn.0000001270Chimeric HLA Antibody Receptor (CHAR) T Cells to Specifically Eliminate HLA-DQ–Specific B Cells
Carolt Arana, Ilse Gille, Renate Hagedoorn, Ainhoa García-Busquets et al.
2026-09-03 · DOI: 10.1681/asn.0000001244ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome
Nisha Bansal, Petter Bjornstad, Adam P. Bress, Tara I. Chang et al.
2026-09-02 · DOI: 10.1681/asn.0000001231Executive Summary of the ASN Kidney Health Guidance on the Cardiovascular‑Kidney‑Metabolic Syndrome
Sankar D. Navaneethan, Brian Rifkin, Amy K. Mottl
2026-09-02 · DOI: 10.1681/asn.0000001230Cover Image
Jianqing Liang, Liting Chen, Liuyan Xiao, Shihui Lin et al.
2026-09 · DOI: 10.1681/asn.0000001150Table of Contents
2026-09 · DOI: 10.1681/asn.0000001250Impaired BCAA Catabolism Drives Peritoneal Fibrosis via BCKA-Mediated Suppression of the Pentose Phosphate Pathway
Jiayang Li, Tiangang Wu, Junhao Dai, Xin Zhao et al.
2026-09-01 · DOI: 10.1681/asn.0000001241Dialysis Access without Guesswork
Erin Moore, Jaime Haak, Paola Fernadez, Shannon Beardsley et al.
2026-08-31 · DOI: 10.1681/asn.0000001267Dismissing the Chaperone in the Diabetic Kidney
Sandeep K. Mallipattu
2026-08-27 · DOI: 10.1681/asn.0000001237Dialysis Discontinuation Rates at Low Levels of Kidney Function in Patients with Acute Kidney Injury on Intermittent Hemodialysis
Ian McCoy, Kathleen D. Liu, Edward Siew, Delphine S. Tuot et al.
2026-08-25 · DOI: 10.1681/asn.0000001245Modernizing Kidney Transplant Referral
Amber B. Paulus, Johanna Christensen, Nilang Patel, Scott Silvey et al.
2026-08-25 · DOI: 10.1681/asn.0000001259Ciliary ARL13B Drives Cystogenesis in the Kidney via Its GEF Activity
Robert E. Van Sciver, Avery Forster, Leslie M. Lewis, Tamara Caspary et al.
2026-08-24 · DOI: 10.1681/asn.0000001238Normalization Benchmarking for nCounter Diagnostics Requires Deployment- and Biology-Aware Evaluation
Dina Zielinski
2026-08-24 · DOI: 10.1681/asn.0000001206Renin Is Critical for Renin Lineage Cell Plasticity, Migration, and Disease Outcome in Experimental Crescentic Glomerulonephritis
Shila Azizolli, Sagor Halder, Anne Steglich, Akua Annoh et al.
2026-08-24 · DOI: 10.1681/asn.0000001239Authors' Reply: Normalization Benchmarking for nCounter Diagnostics Requires Deployment- and Biology-Aware Evaluation
Alexis Piedrafita, Marta Sablik, Alexandre Loupy
2026-08-24 · DOI: 10.1681/asn.0000001234Indoxyl Sulfate Promotes Uremic Arterial and Venous Thrombosis by Stabilizing IDO1 via the E3 Ligase SHFM3
Ricardo Almiron, Abbas Brahim Malloum, Saran Lotfollahzadeh, Kashvi Sethuraman et al.
2026-08-21 · DOI: 10.1681/asn.0000001203Interpreting Donor-Derived Cell-Free DNA
Amandine Meudec, Olivier Aubert
2026-08-21 · DOI: 10.1681/asn.0000001240Reviews
Community Reviews
Version History
April 22, 2025 at 10:52 am
April 22, 2025